Christopher Causey United Therapeutics Corp (UTHR) insider trading activity

Christopher Causey is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 4,185 shares of UTHR, which is worth approximately $1.15 Million. The most recent transaction as insider was on May 15, 2024, when has been sold 2,000 shares (Common Stock) at a price of $272.9 per share, resulting in proceeds of $545,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.19K

0% 3M change

47.62% 12M change

Total Value Held $1.15 Million

CHRISTOPHER CAUSEY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2024	SELL Open market or private sale	$545,800 $272.9 p/Share	2,000 Reduced 32.34%	4,185 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	$224,280 $112.14 p/Share	2,000 Added 24.43%	6,185 Common Stock
May 03 2024	SELL Open market or private sale	$582,198 $259.91 p/Share	2,240 Reduced 34.86%	4,185 Common Stock
May 03 2024	BUY Exercise of conversion of derivative security	$251,193 $112.14 p/Share	2,240 Added 25.85%	6,425 Common Stock
Dec 15 2023	SELL Open market or private sale	$102,000 $255.0 p/Share	400 Reduced 8.72%	4,185 Common Stock
Dec 12 2023	SELL Open market or private sale	$749,040 $249.68 p/Share	3,000 Reduced 39.55%	4,585 Common Stock
Dec 12 2023	BUY Exercise of conversion of derivative security	$526,290 $175.43 p/Share	3,000 Added 28.34%	7,585 Common Stock

Jul 07 2023	BUY Exercise of conversion of derivative security	-	1,750 Added 27.62%	4,585 Common Stock
Jan 03 2023	SELL Open market or private sale	$276,260 $276.26 p/Share	1,000 Reduced 26.08%	2,835 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	$175,430 $175.43 p/Share	1,000 Added 20.68%	3,835 Common Stock
Nov 03 2022	SELL Open market or private sale	$650,000 $260.0 p/Share	2,500 Reduced 46.86%	2,835 Common Stock
Nov 03 2022	BUY Exercise of conversion of derivative security	$438,575 $175.43 p/Share	2,500 Added 31.91%	5,335 Common Stock
Nov 02 2022	SELL Open market or private sale	$1,225,000 $245.0 p/Share	5,000 Reduced 63.82%	2,835 Common Stock
Nov 02 2022	BUY Exercise of conversion of derivative security	$877,150 $175.43 p/Share	5,000 Added 48.38%	5,335 Common Stock
Aug 23 2022	SELL Open market or private sale	$787,360 $224.96 p/Share	3,500 Reduced 55.25%	2,835 Common Stock
Aug 23 2022	BUY Exercise of conversion of derivative security	$614,005 $175.43 p/Share	3,500 Added 35.59%	6,335 Common Stock
Jul 08 2022	BUY Exercise of conversion of derivative security	-	2,160 Added 43.24%	2,835 Common Stock
Jun 27 2022	SELL Open market or private sale	$1,183,950 $236.79 p/Share	5,000 Reduced 88.11%	675 Common Stock
Jun 27 2022	BUY Exercise of conversion of derivative security	$381,800 $76.36 p/Share	5,000 Added 46.84%	5,675 Common Stock
May 27 2022	SELL Bona fide gift	-	75 Reduced 10.0%	675 Common Stock
May 26 2022	SELL Open market or private sale	$1,124,100 $224.82 p/Share	5,000 Reduced 86.96%	750 Common Stock
May 26 2022	BUY Exercise of conversion of derivative security	$381,800 $76.36 p/Share	5,000 Added 46.51%	5,750 Common Stock
Aug 06 2021	SELL Open market or private sale	$548,100 $210.0 p/Share	2,610 Reduced 77.68%	750 Common Stock
Aug 06 2021	BUY Exercise of conversion of derivative security	$199,300 $76.36 p/Share	2,610 Added 43.72%	3,360 Common Stock
May 26 2021	SELL Bona fide gift	-	75 Reduced 9.09%	750 Common Stock

Christopher Causey

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account